Erbitux (Cetuximab) - Investigational Biological Cancer Therapy

Print

Over expression of EGFR correlates with increased metastasis, decreased survival and a poor prognosis. (Source: ABPI)
 
«Back | Next»




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development